Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cancer Research Communications|January 16, 2023
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patientHenkel Valentine, William Aiken, Belinda Morrison, et al.
Blood|April 22, 2015
Central nervous system acute lymphoblastic leukemia: role of natural killer cellsLiron Frishman-Levy, Avishai Shemesh, Allan Bar-Sinai, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cellsLanlan Zhou, Kelsey Huntington, Shengliang Zhang, et al.
Oncotarget|November 27, 2020
MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infectionLanlan Zhou, Kelsey Huntington, Shengliang Zhang, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
Cancer Discovery|June 20, 2022
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular CarcinomaTuran Aghayev, Aleksandra M Mazitova, Jennifer R Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor TherapyH Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Cancer Discovery|October 31, 2020
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and ImmunosuppressionRalph Francescone, Débora Barbosa Vendramini-Costa, Janusz Franco-Barraza, et al.
Pageof 9